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ABSTRACT Recently, diverse hematologic parameters have been used as an in-
dicator of the presence or severity of inflammatory and cardiovascular diseases. 
Our aim was to investigate the ratios of neutrophils to lymphocytes (NL), mono-
cytes to high-density lipoprotein (HDL) cholesterol (MHC), and platelets to lym-
phocytes (PL) in patients with rosacea in comparison with the control group and 
determine whether there was a correlation between these ratios and metabolic 
disorders in patients with rosacea. We conducted a case-control study on 61 pa-
tients with rosacea and 60 healthy controls between January 2015 and January 
2016 at the Dermatology Outpatient Clinic, Mugla, Turkey. Demographic data, 
biochemical parameters, hematologic parameters and ratios, the presence of 
metabolic syndrome (MS), and the presence of insulin resistance (IR) in the par-
ticipants were recorded. Sixty one patients with rosacea (16 men, 45 women) 
and 60 controls (13 men, 47 women) were included in the study. The NL ratio, 
mean levels of low-density lipoprotein (LDL) and total cholesterol, triglyceride, 
C-reactive protein (CRP), systolic and diastolic blood pressures, and the presence 
of IR were significantly higher in patients with rosacea than in controls. In the 
rosacea group, the MHC ratio was significantly higher in patients with rosacea 
with IR and MS. Moreover, only the MHC ratio was an independent predictor of 
MS according to univariate logistic regression analysis. The cutoff value of MHC 
on admission for predicting MS in patients with rosacea was 0.013.The higher 
levels of NL ratio and IR in the rosacea group corroborate the previous studies 
demonstrating a high level of cardiovascular risk factors in patients with rosa-
cea. The MHC ratio may be used as a simple and inexpensive method to predict 
metabolic disorders in patients with rosacea.    
KEY WORDS: hematologic parameters, insulin resistance, metabolic syndrome, 
rosacea 
INTRODUCTION
Various hematologic parameters or ratios have re-
cently been used as an indicator of the presence or 
severity of inflammatory diseases. Insulin resistance, 
coronary artery disease, hypertension, and inflam-
matory skin diseases such as psoriasis and Behçet’s 
disease have been evaluated (1-5). Rosacea is also a 
chronic inflammatory skin disease (6). It has been pro-
posed that inflammation related to the excessive re-
sponse of the innate immune system by various trig-
gers plays a key role in the pathogenesis of rosacea 
(7-11). In recent studies, dyslipidemia, hypertension, 
and cardiovascular risk factors have been reported 
to be high in patients with rosacea (6,12,13). Further-
more, there was a very recent report on the increased 
frequency of insulin resistance and some parameters 
of metabolic syndrome in patients with rosacea (14).  
To the best of our knowledge, there is no study in-
vestigating the hematological ratios in patients with 
rosacea or the relationship between these ratios and 
metabolic disorders accompanying rosacea.      
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Our aim was to investigate the neutrophil-to-lym-
phocyte (NL), monocyte-to-high-density lipoprotein 
(HDL) cholesterol (MHC), and platelet-to-lymphocyte 
(PL) ratios in patients with rosacea in comparison 
with the control group and determine whether there 
was a correlation between these ratios and metabolic 
syndrome and insulin resistance in patients with ro-
sacea.   
METHODS
We conducted a case-control study on 61 pa-
tients with rosacea and 60 healthy controls (matched 
for age, sex, and body mass index) between January 
2015 and January 2016 at the Dermatology Outpa-
tient Clinics of the Mugla Sitki Kocman University 
Training and Research Hospital. Ethic Committee ap-
proval was obtained before the study from the local 
hospital Ethic Committee. The diagnosis of rosacea 
was based on characteristic clinical findings accord-
ing to the National Rosacea Society criteria. The con-
trols were selected randomly from the patients who 
were admitted to the outpatient clinic with various 
skin problems other than rosacea. Inclusion criteria 
for the participants were absence of known diabetes 
mellitus, coronary artery disease, hyperlipidemia, and 
chronic inflammatory disease (including inflamma-
tory skin diseases). 
Age, sex, body mass index (BMI), lipid profile (to-
tal cholesterol, triglyceride, low-density lipoprotein, 
and high-density lipoprotein), fasting blood glucose 
(FBG), insulin, C-reactive protein (CRP), the ratios of 
NL, MHC, and PL (obtained from the complete blood 
count), systolic and diastolic blood pressure levels, 
and the presence of metabolic syndrome (MS) and 
insulin resistance (IR) were recorded.   
BMI was calculated using the formula weight (kg) 
/ height (m2). Lipid parameters, insulin, and FBG lev-
els were studied after a 12-hour fasting period. Based 
on the diagnostic criteria of the International Diabe-
tes Federation (IDF-2005), MS was defined as waist 
circumference  >94cm in men and >80cm in women 
plus at least two of the following criteria: triglyceride 
value >150 mg/dL or specific treatment for this lipid 
abnormality, high density lipoprotein; <40 mg/dL in 
Table 1. Comparison of the demographic, biochemical, metabolic, and hematologic parameters in the ro-
sacea and control groups
Rosacea group
n (%) or mean ± SD
Control group









Age 50.46±8.58 49.80±9.70 0.693
BMI (kg/m2) 28.19±3.76 27.18±3.36 0.123
LDL (mg/dL) 129.87±31.46 119±26.39 0.042
HDL (mg/dL) 57.19±14.51 57.62±16.69 0.938
T. cholesterol (mg/dL) 214±35.47 199.76±34.89 0.028
Triglyceride (mg/dL) 83.09±8.79 76.04±9.39 0.036
FBG (mg/dL) 96.42±14.53 91.83±7.36 0.128
Systolic BP (mmHg) 126.80±16.71 118.50±14.12 0.004
Diastolic BP (mmHg) 82.29±9.20 75.83±9.26 <0.001
Presence of IR 22 (36.1) 11 (18.3) 0.029
Presence of MS 21 (34.4) 13 (21.6) 0.118
CRP (mg/dL) 3.33±3.11 2.26±2.22 0.016
Neutrophil count (K/mL) 2.19±0.99 1.75±0.62 0.088
Lymphocyte count (K/mL) 1.97±0.63 2.05±0.55 0.455
Platelet count (K/mL) 244.21±57.87 258.96±66.35 0.195
Monocyte count (K/mL) 0.39±0.12 0.35±0.16 0.106
NL ratio 2.11±0.97 1.73±0.64 0.012
MPV ratio 9.29±1.01 9.61±1.21 0.115
MHC ratio 0.0073±0.0030 0.0067±0.0047 0.447
PL ratio 132.73±45.06 131.58±36.58 0.880
Chi-square test, Student’s t-test, and Mann-Whitney U test. BMI: body mass index; FBG: fasting blood glucose; BP: blood pres-
sure; IR: insulin resistance; MS: metabolic syndrome; CRP: C-reactive protein; NL: neutrophil/lymphocyte; MHC: monocyte/ 
high-density lipoprotein (HDL) cholesterol; LDL: high-density lipoprotein; PL: platelet/lymphocyte; MPV: mean platelet vol-
ume; SD: Standard Deviation
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men and <50 mg/dL in women or specific treatment 
for this lipid abnormality, blood pressure ≥130/85 
mmHg or antihypertensive treatment, and fasting 
blood glucose ≥100 mg/dL or diagnosed diabetes 
mellitus (15).  
Insulin resistance was calculated using the homeo-
stasis model assessment of insulin resistance (HOMA-
IR) according to the following formula: [fasting insulin 
level (uIU/mL) × fasting glucose level (mg/dL)/405]. A 
value of >2.7 was considered to indicate IR.  
For the data analysis, the statistical program “SPSS 
for windows 20.0” was used. The chi-square test was 
used for the analysis of qualitative data. The distribu-
tion of variables was checked with the Kolmogorov-
Smirnov test. The Student’s t-test and Mann-Whitney 
U-test were used for variables with normal and ab-
normal distribution, respectively. P<0.05 was consid-
ered significant.  
RESULTS
Sixty one rosacea patients (16 men, 45 women; age 
range 35-74 years) and 60 healthy controls (13 men, 
47 women; age range 33-78 years) were included in 
the study. The duration of the disease varied between 
3 months to 20 years (mean ± Standard Deviation: 
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NL ratio 2.15±1.04 2.08±0.95 0.088 2.39±1.09 1.96±0.89 0.088
MHC ratio 0.0080±0.0034 0.0069±0.0027 0.008 0.0087±0.0031 0.0066±0.0027 0.007
PL ratio 140.43±54.44 128.39±38.92 0.505 138.11±59.73 129.92±35.65 0.505
Neutrophil count 
(K/mL)
3.74±0.90 3.88±1.59 0.448 2.39±1.09 1.96±0.89 0.088
Lymphocyte count 
(K/mL)
2.01±0.85 1.95±0.47 0.387 1.87±0.88 2.02±0.45 0.387
Platelet count 
(K/mL)
252.32±62.16 239.64±55.62 0.084 226.52±54.19 253.50±58.22 0.084
MPV (fl) 9.03±0.99 9.44±1.01 0.376 9.45±1.01 9.21±1.02 0.376
Monocyte count 
(K/mL)
0.39±0.12 0.39±0.12 0.840 0.40±0.11 0.39±0.13 0.840
Student’s t-test and Mann-Whitney U test. IR: insulin resistance; MS: metabolic syndrome; NL: neutrophil/lymphocyte; MHC: 
monocyte/ high-density lipoprotein (HDL) cholesterol; PL: platelet/lymphocyte; MPV: mean platelet volume; SD: Standard 
Deviation
Figure 1. Correlation between the neutrophil–to-lympho-
cyte (NL) ratio and C-reactive protein (CRP) levels in pa-
tients with rosacea.
Figure 2. Receiver operating the characteristics curve of 
monocyte count to high-density lipoprotein (HDL) choles-
terol (MHC) ratio for predicting metabolic syndrome in pa-
tients with rosacea (AUC: Area under the curve) 
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1.75±3.53 years) in patients with rosacea. Of the pa-
tients, 29 (47.5%) had the erythematotelangiectatic 
type of rosacea, while 31 (50.8%) had papulopustular 
type and one (1.6%) had the phymatous type. 
Among the hematological ratios, the NL ratio of 
the rosacea group was significantly higher than in the 
control group (P=0.012). The NL ratio levels were cor-
related with CRP levels (P<0.05) (Figure 1). Other than 
the NL ratio, the mean levels of LDL, total cholesterol, 
triglyceride, CRP, systolic and diastolic blood pres-
sures, and presence of IR were significantly higher in 
patients with rosacea than those of controls (P<0.05) 
(Table 1).    
When we evaluated only the rosacea group, the 
MHC ratio was significantly higher in the patients 
with MS and IR (P=0.007 and P=0.008, respectively) 
(Table 2). There was no correlation between rosacea 
subtype and hematological ratios (P>0.05). In addi-
tion, only the MHC ratio was an independent predic-
tor of MS in the rosacea group, according to univari-
ate logistic regression analysis (P=0.015, OR: 1.54, CI: 
1.723-1.371). The cutoff value of the MHC ratio on 
admission for predicting MS in patients with rosacea 
was 0.013 with 9.5% sensitivity and 97.5% specificity 
(area under the curve 0.712, P=0.013) (Figure 2).     
DISCUSSION
Diverse hematologic ratios have recently become 
popular for predicting the course of cardiovascular 
diseases, various cancers, and inflammatory diseas-
es. Since rosacea is an inflammatory disease with a 
known association with cardiovascular diseases, we 
conducted the current study to determine whether 
the hematological ratios may be used to predict met-
abolic disorders accompanying rosacea. We found 
that the NL ratio of patients with rosacea was signifi-
cantly higher than that of controls, and that the MHC 
ratio significantly higher in patients with rosacea with 
MS and IR.   
Although the pathogenesis of rosacea has not 
been completely elucidated, increased levels of cat-
helicidin peptides (LL-37), kallikrein-5 (KLK5), toll-like 
receptor 2 (TLR2), endoplasmic reticulum (ER) stress, 
oxidative stress, and pro-inflammatory cytokines 
(TNF-α, IL-8, and IL-1β) have been found in rosacea-
effected skin (7-11). Similar pathogenetic mecha-
nisms such as ER stress, oxidative stress, high LL-37 
levels, and high inflammatory cytokines have been 
demonstrated in the development of atherosclerosis, 
MS, and cardiovascular diseases (16-19). Although 
Egeberg et al. did not find an association between 
rosacea and increased risk of adverse cardiovascular 
outcomes or death, an association between rosacea 
to cardiovascular diseases, MS, and IR have been re-
ported in some studies (6,12-14,20).
Similarly to rosacea, psoriasis and Behçet’s dis-
ease are chronic inflammatory skin diseases which 
are associated with metabolic syndrome and cardio-
vascular diseases. Moreover, psoriasis and Behcet’s 
disease are also systemic diseases, which is not the 
case with rosacea. The hematologic ratios have been 
used in psoriasis and Behcet’s disease to determine 
underlying inflammation or cardiovascular risk fac-
tors. Yurtdas et al. found that the NL ratio was sig-
nificantly higher and the only predictor of subclini-
cal atherosclerosis in patients with psoriasis (4). Sen 
et al. have reported similar high NL ratios in patients 
with psoriasis and a positive correlation between the 
NL ratio and CRP levels (21). Furthermore, both the 
NL and PL ratios have been noted as strong predic-
tors of psoriatic arthritis in a study involving patients 
with psoriasis, psoriatic arthritis, and healthy controls 
(22). In another two studies, the NL ratio and carotid 
intima media thickness have been found to be high 
in patients with Behçet’s disease (23,24). These re-
sults corroborate the hypothesis that inflammation 
and endothelial dysfunction have an important role 
in the pathogenesis of Behçet’s disease, and that NL 
ratio may be used to evaluate the disease activity. 
Additionally, Rifaioglu et al. noticed that the NL ratio 
was significantly increased in patients with active Be-
hçet’s disease (5). Alan et al. have suggested that NL 
ratio may be a diagnostic criterion of Behçet’s disease 
based on the results of their study (25).
The hematologic ratios, particularly NL and MHC 
ratios, were first used for cardiovascular diseases, 
metabolic disorders, and some cancers. Several stud-
ies showed that NL ratio is an inexpensive and easy 
indicator of atherosclerosis, hypertension, and in-
flammation (2,3). Furthermore, Lou et al. noticed that 
the NL ratio and IR were significantly associated (1). 
Buyukkaya et al. also found a relationship between 
NL ratio and MS, as well as severity of MS. In a cross-
sectional study consisting of 1070 individuals, in-
creased NL ratio levels were significantly related to 
chronic diseases such as hypertension and diabetes 
mellitus (26). It has been proposed that neutrophils 
increase damage to the endothelium by interacting 
with endothelial tissue and that they play a key role in 
the development of inflammation, and thus athero-
sclerosis (2). 
MHC ratio has been found to be high in patients 
with slow coronary flow, as reported by Canpolat et al 
(27). In another study, 340 patients with chronic renal 
disease were followed for about 33 months, finding 
that cardiovascular events were more common in 
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patients with high MHC ratio (28). Monocytes interact 
with damaged endothelium and induce over-expres-
sion of pro-inflammatory cytokines and adhesion 
molecules. Contrarily, HDL cholesterol has anti-in-
flammatory, anti-oxidant, and vasodilator effects (27). 
Thus, MHC ratio has been considered a good indica-
tor of inflammatory conditions such as cardiovascular 
events. In order to provide a fair comparison, since a 
relationship between these hematological ratios and 
obesity has been previously reported, our study in-
cluded BMI-matched subjects in the rosacea and 
control groups. When the rosacea and control groups 
were compared, the NL ratios of the rosacea group 
were significantly higher than those of control group. 
However, only MHC ratio was an independent predic-
tor of MS in patients with rosacea.
CONCLUSION 
The presence of high cardiovascular risk factors 
among patients with rosacea in recent studies en-
couraged us to perform the current study. The high-
er levels of NL ratio and IR we found in the rosacea 
group corroborate the previous studies, demonstrat-
ing the presence of high cardiovascular risk factors in 
patients with rosacea. In the rosacea group, MHC ra-
tio was significantly higher in patients with MS and IR. 
MHC ratio may be used as a simple and inexpensive 
method to indicate metabolic disorders accompany-
ing rosacea. Further studies are needed to duplicate 
our results and to evaluate the usefulness of hemato-
logic parameters for predicting metabolic disorders 
in rosacea.  
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